Reposted from Quora. This is a fas­ci­nat­ing expla­na­tion of why China was capa­ble of gain­ing a cer­tain amount of con­trol over the spread of COVID-19. The arti­cle fur­ther exposes the sig­nif­i­cant weak­nesses of the United States, mak­ing it clear that we are not well-positioned to effec­tively deal with the Sars-Cov-2 pan­demic: As some­one who lives in China, how do you feel they are com­bat­ing COVID-19?

Accord­ing to the authors:

We iden­ti­fied 24 clin­i­cal tri­als, involv­ing more than 20 med­i­cines, such as human immunoglob­u­lin, inter­fer­ons, chloro­quine, hydrox­y­chloro­quine, arbidol, remde­sivir, favipi­ravir, lopinavir, riton­avir, oseltamivir, methyl­pred­nisolone, beva­cizumab, and tra­di­tional Chi­nese med­i­cines (TCM).

The full paper can be found here: Clin­i­cal tri­als on drug repo­si­tion­ing for COVID-19 treatment